Table 2.
Adverse event | Case # | Incidence (%) |
---|---|---|
AF-related thromboembolism | ||
Ischemic stroke | 8 | 4.26 |
Lower extremity deep venous thrombosis | 19 | 10.11 |
Other-system thrombosis | 5 | 2.66 |
Arterial thrombosis | ||
Acute myocardial infarction | 22 | 11.70 |
Unstable Angina | 14 | 7.45 |
Bleeding | ||
Cerebral hemorrhage | 8 | 4.26 |
Clinically relevant major bleeding | 18 | 9.57 |
Non-clinically relevant major bleeding | 9 | 4.79 |
Minor bleeding | 36 | 19.15 |
All-cause death | 54 | 28.72 |
AF, atrial fibrillation; Other-system thrombosis: mesenteric thrombosis, venous catheter-related thrombosis, etc.; Clinically relevant major bleeding: hemoglobin decreased more than 2 g/L, the need for blood transfusion or hospitalization, or bleeding in major organs, fatal bleeding, etc.; Non-clinically relevant major bleeding: chronic bleeding, hemoglobin decreased less than 2 g/L; Minor bleeding: subcutaneous hematoma, gastrointestinal bleeding (less than the standards of major bleeding), blood sputum, etc.